Manufacturer Periodic Summary Report (PSR) for Serious Incidents

Introduction

The Manufacturer Periodic Summary Report (PSR) is a critical regulatory requirement under the Medical Device Regulation (EU 2017/745) and In Vitro Diagnostic Regulation (EU 2017/746). This document serves as a comprehensive tool for manufacturers to systematically review and report serious incidents, field safety corrective actions (FSCAs), and trends related to their medical devices.

Unlike the previous directives, MDR and IVDR have introduced more stringent requirements for post-market surveillance, with the PSR playing a central role in demonstrating ongoing compliance and patient safety commitment.

Regulatory Basis for PSR

The legal requirements for PSR are established in:

• MDR Article 88 Periodic safety update report for medical devices
• IVDR Article 82 Periodic safety update report for in vitro diagnostic medical devices
• Commission Implementing Regulation (EU) 2021/2226 Detailed rules for PSR format and content

When is a PSR Required?

PSR requirements vary based on device classification:

Device Type	Reporting Frequency
Class III implantable devices	Annually
Class III non-implantable devices	Every 2 years
Class IIb devices	Every 5 years
Class D IVDs	Annually
Class C IVDs	Every 2 years
Class B IVDs (self-test)	Every 5 years

Content Requirements

Serious Incidents Reporting

PSR must include a summary of serious incidents reported during the reference period, including:

• Total number of serious incidents reported
• Number of serious incidents for each type (deaths, serious injuries, etc.)
• Number and nature of serious incidents that do not require reporting under the de minimis exemption
• Incidents reportable on a periodic basis rather than immediately

Field Safety Corrective Actions

All field safety corrective actions undertaken during the reporting period should be documented, including:

• Description of the FSCA
• Reason for the action
• Communication methods
• Effectiveness of the action
• Documentation of implementation

Trend Reporting

The PSR should include analysis of statistical trends that indicate a potential risk that could lead to serious incidents. This includes:

• Identification of statistically significant increases in incident frequency
• Trends in specific device issues or failure modes
• Geographical clustering of incidents
• Changes in incident severity patterns
• Comparison with previous reporting periods

Benefits-Risk Assessment

Manufacturers must provide an overall benefit-risk assessment, including:

• Current knowledge about the device's benefits and risks
• Evaluation of new information that affects the benefit-risk balance
• Any new information about the availability of alternative treatments or diagnostics
• Impact of the benefit-risk assessment on the continued market availability of the device

Conclusion and Follow-up Actions

The PSR should conclude with:

• Overall conclusion regarding the benefit-risk balance
• Description of any corrective and preventive measures implemented
• Statement regarding the need for any further investigations or actions
• Plans for modifying the marketing authorization or device design (if applicable)

PSR Submission Process

Procedures for PSR submission include:

• Submission through the EUDAMED database once fully functional
• Provisional submission through national competent authorities during the transition period
• Timeline: within 60 days of the end of the reporting period
• Language: official language of the member state where the device is marketed

Best Practices for PSR Preparation

Common Challenges and Solutions

Challenge	Potential Solution
Incomplete or inaccurate device distribution data	Implement sales tracking systems with device level granularity
Determining statistical significance for trends	Establish predefined statistical methods and thresholds
Handling under-reporting of incidents	Implement proactive surveillance programs and user engagement initiatives
Organizing data across multiple product lines	Develop standardized data collection and classification methodologies

Recent Regulatory Developments

Important updates to PSR requirements include:

• Greater emphasis on trend reporting capabilities
• Increased requirement for benefit-risk assessment justification
• Expanded requirements for documentation of post-market surveillance activities
• Enhanced focus on user experience and usability in incident analysis

Conclusion

The Manufacturer Periodic Summary Report represents both a regulatory requirement and a valuable opportunity for manufacturers to demonstrate commitment to patient safety and product improvement. A well-prepared PSR provides a systematic approach to post-market surveillance that can enhance device quality, identify emerging risks, and support informed decisions about continued market presence.

Effective PSR processes integrate seamlessly with broader quality management and post-market surveillance systems, creating a continuous improvement loop that benefits manufacturers, healthcare providers, and ultimately patients.